Navigation Links
A Fish a Day to Keep the Cancer Doctor Away?

Sturgeon Bay, WI (PRWEB) November 26, 2013

Breast cancer is the most common cancer worldwide, responsible for 23% of all cancer cases and 14% of all cancer deaths in 2008. Sturgeon Bay, Wisconsin Chiropractor and Naturopath Dr. J G Moellendorf, DC, ND, LCP relates that while the initial cause of breast cancer is unknown, research suggests that there is a high correlation with dietary habits, especially the types of fat eaten.

A research team led by Duo Li at Zhejiang University, Hangzhou, China reviewed 26 publications covering 21 independent research studies monitoring women for the development of breast cancer from 4.3 to 20 years. The studies included 20,905 cases of breast cancer among 883,585 individuals up through December 2012. They published their findings in the June 2013 British Medical Journal titled “Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies.”

Comparisons of decreased breast cancer risk were done between each of the omega-3 fatty acids along with total fish intake. The risk of developing breast cancer was reduced by as much as 14% in those taking an omega-3 fish based fatty acid supplement, whether eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), or docosapentaenoic acid (DPA). The breast cancer risk was reduced by 5% for each 0.1 gram of omega-3s consumed daily. On the other hand, there was no meaningful decrease in breast cancer risk in those taking an alpha-linolenic acid (ALA) supplement or increasing their consumption of fish.

The researchers conclude that their findings have implications for preventing breast cancer by means of dietary and lifestyle interventions.

David W L Ma’s research team at the University of Guelph, Ontario, Canada found similar results when testing a novel strain of mice. A specially bred type of mice known as fat-1, are able to convert omega-6 fatty acids into omega-3 fatty acids. Omega-6s are very inflammatory in the body, which can lead to many diseases including cancer. Omega-3s have anti-inflammatory properties in the body, and have been shown to reduce the development of cancer. The researchers crossbred fat-1 mice with mouse mammary tumor virus mice (MMTV-neu(ndl)-YD5), which are used as a model to test aggressive breast cancer. The results in the crossbred fat-1/MMTV-neu(ndl)-YD5 mice and the MMTV-neu(ndl)-YD5 mice with a high omega-3 diet were virtually the same: a 30% reduction in tumor size and a 33% reduction in the number of cancer tumors developed. The results were published in the Journal of Nutritional Biochemistry February 2013 titled “Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids.”

The sixth most common cancer is squamous-cell carcinoma of the mouth. “Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2” was published in Carcinogenesis, July 2013. Researchers at the London School of Medicine and Dentistry, Queen Mary University of London, England led by Eric Kenneth Parkinson found that the omega-3 fatty acids EPA and DHA cause death in both pre-malignant and malignant cancer cells while having no bad effects on normal cells. They concluded that omega-3 rich foods can assist in the prevention and treatment of oral and skin cancers.

The conclusion of these recent research papers is that a quality fish oil supplement containing at least 300 milligrams each of EPA and DHA of marine based omega-3 fatty acids can reduce the incidence of breast cancer by 14 to 33 per cent and may be beneficial in preventing and treating squamous cell cancers of the mouth and skin. Supplementing with alpha-linolenic acid such as flax seed oil, or eating more cold water fatty fish such as salmon, has not been shown to have these same benefits in reducing the risk of developing cancer.

Using the latest research findings, Moellendorf Chiropractic Office, Ltd. uses a comprehensive package of Chiropractic care, decompression traction therapy, active therapeutic movement training, cold laser therapy, and nutrition for the natural treatment of neurological conditions, neck and back pain, and other health conditions without drugs or surgery. Additional information about Chiropractic, Naturopathy, and other forms of natural health care has been provided by Moellendorf Chiropractic Office, Ltd. at

About: Dr. J G Moellendorf, DC, ND, LCP

Dr. J G Moellendorf, DC, ND, LCP attended the University of Wisconsin—Superior where he majored in Physics and Mathematics, with a minor in art photography. While attending the University of Minnesota—Minneapolis, he assisted in research on ribosomal proteins. Completing his Chiropractic studies at Palmer College of Chiropractic in Davenport, Iowa, he graduated Cum Laude (with high honors) in 1983. He started Moellendorf Chiropractic Office, Ltd. in Sturgeon Bay, Wisconsin in 1983. In 1996, Dr. Moellendorf was awarded his Doctorate in Naturopathy from Trinity School of Natural Health. In 2001, he received Chiropractic’s most prestigious award, the honorary Legion of Chiropractic Philosophers degree, for his thesis “The Workings of Innate Intelligence in Obsessive/Compulsive and Addictive Behaviors.” This paper was chosen for publishing in the book Philosophic Contemplations vol. 2 in 2002. In June of 2012, Dr. Moellendorf authored his first book titled Healthcare’s Best Kept Secret which can be ordered on Amazon. Dr. Moellendorf can be contacted by phone (920) 493-2126, fax (920) 743-1145, email jgmoellendorf(at)itol(dot)com, his website at, or send a carrier pigeon to 44.84722N and 87.36416W.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
2. Berg Launches First-Ever Stratified Medicine Clinical Trial To Investigate Cancer Metabolism Of Solid Tumors
3. Associates for Breast and Prostate Cancer Studies Honors Ann-Margret, Robert Wagner and Bill and Roseann Patterson at 24th Annual The Talk of the Town Gala
4. Huntsman Cancer Institute Uses Linguamatics I2E to Automatically Extract Insights from Clinical Pathology Documents
5. QIAGEN Announces Third Co-Development Program for Companion Diagnostics Paired With Lillys Investigational Cancer Compounds
6. Annai Systems to Support International Challenge to Improve the Detection of Cancer Mutations
7. VolitionRx Expands Sample Size to 11,000 in Pivotal Colorectal Cancer Trial with Hvidovre Hospital, Denmark
8. Donations Required to Finalize Development of Cancer Detecting Breath Device
9. Edith Sanford Breast Cancer Partners with Athena Breast Health Network to Personalize Breast Cancer Risk Assessment
10. MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of MCT-485, a Noncoding miRNA for Cancer Treatment
11. Cancer Cant Hide; Better Heart Shocks; Mechanical Leeches
Post Your Comments:
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... San Diego-based ... of its corporate rebranding initiative announced today. The bold new look is part ... as the company moves into a significant growth period. , It will also expand ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at . 2016 ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, ... secure authentication solutions, today announced that it has ... Advanced Research Projects Activity (IARPA) to develop next-generation ... program. "Innovation has been a driving ... Thor program will allow us to innovate and ...
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
Breaking Biology News(10 mins):